Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
|
CN |
|
K
|
Kingsemi Co Ltd
SSE:688037
|
CN |
|
C
|
Cloudwalk Technology Co Ltd
SSE:688327
|
CN |
|
I
|
InfuSystem Holdings Inc
AMEX:INFU
|
US |
|
Indra Sistemas SA
F:IDA
|
ES |
|
Jihua Group Corp Ltd
SSE:601718
|
CN |
|
W
|
West China Cement Ltd
HKEX:2233
|
CN |
|
E
|
Emro Incorporated
KOSDAQ:058970
|
KR |
|
Sun Life Financial Inc
TSX:SLF
|
CA |
|
S
|
Scherzer & Co AG
XETRA:PZS
|
DE |
|
Pioneer Credit Ltd
ASX:PNC
|
AU |
|
Krida Jaringan Nusantara Tbk PT
IDX:KJEN
|
ID |
|
Jiangsu Huaxin New Material Co Ltd
SZSE:300717
|
CN |
|
A
|
Al-Salam Real Estate Investment Trust
KLSE:ALSREIT
|
MY |
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
CA |
Bankruptcy Probability
Zhejiang Shengda Bio-Pharm Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Zhejiang Shengda Bio-Pharm Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
Z
|
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
|
3.2B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Zhejiang Shengda Bio-Pharm Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Zhejiang Shengda Bio-Pharm Co Ltd has total debt of 305.5m CNY. This includes both short-term (0 CNY) and long-term (305.5m CNY) debt.
You can find a full breakdown on its Balance Sheet.
